PATENT CLAIM ANALYSIS

Application Number: 16081904
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-06
Patent Classification: ["514", "064000"]

Abstract:
Compounds, pharmaceutical formulations, and methods of treating bacterial infections are disclosed.

Claim (Index 5):
The compound of  claim 1 , or a salt or a hydrate or a solvate thereof, wherein said X is wherein\n R d  is selected from the group consisting of halogen, substituted or unsubstituted alkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, \u2014OR 15 , \u2014SR 15 , \u2014S(O)R 15 , \u2014NR 15 R 16 , \u2014C(O)R 15 , \u2014CH 2 C(O)OR 15 , and \u2014CH 2 C(O)NR 15 R 16  \n wherein R 15  and R 16  are each independently selected from the group consisting of H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl \n \n and wherein R 15  and R 16 , along with the nitrogen to which they are connected, are optionally joined to form a substituted or unsubstituted 4- to 8-membered ring.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16081902', '15718422', '15986747', '13606949', '14688581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7222453350986939
- 35 USC 102 Novelty (BERT): 0.548674250973159
- Combined Prediction Score: 0.7048882266861405
- Mean Citation Score: 255.67250400000003
- Max Citation Score: 390.4352
- Similarity Product: 306.63357665138244

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test